Quest Diagnostics (DGX) Oct IV elevated at 43 into Q3 EPS
Quest Diagnostics (NYSE: DGX) October call option implied volatility is at 43, November is at 26; compared to its 52-week range of 13 to 31 into the expected release of Q3 results on October 19.
